Doctors explain how Wegovy and Ozempic work

Doctors explain that Wegovy and Ozempic work by mimicking a natural hormone your body already produces—GLP-1 (glucagon-like peptide-1)—but in a more powerful, longer-lasting form . The key difference is their approved purpose: Ozempic is for type 2 diabetes, while Wegovy is specifically for chronic weight management .

🧬 The Core Mechanism: Mimicking Your “Fullness” Hormone

GLP-1 is a hormone released by your intestines after you eat. It sends signals throughout your body to help manage blood sugar and appetite . Wegovy and Ozempic contain semaglutide, a lab-made version of GLP-1 that binds to the same receptors but resists breakdown, so it stays active in your body much longer .

Doctors explain that this amplified GLP-1 signal triggers several key effects:

• Slows Stomach Emptying: It tells your stomach to empty more slowly into the intestines. This keeps food in your stomach longer, so you feel physically full for an extended period and your blood sugar rises more gradually after meals .
• Signals “Fullness” to the Brain: It travels to the hypothalamus, the brain’s appetite control center. There, it activates neurons that make you feel satisfied and quiets the ones that drive hunger .
• Reduces “Food Noise” and Cravings: Many patients describe a profound reduction in constant thoughts about food. Doctors note this quiets the mental chatter and cravings, making it easier to stick to healthier eating patterns .
• Manages Blood Sugar (Pancreas Effect): This is the primary role for Ozempic. It tells the pancreas to release insulin only when blood sugar is high and reduces glucagon (a hormone that raises blood sugar), helping to keep levels stable without causing dangerous lows .

⚖️ Why Wegovy and Ozempic Are Prescribed Differently

Even though they use the same active ingredient, doctors explain they are distinct tools for distinct goals:

• Ozempic (Semaglutide, lower doses): Approved for type 2 diabetes. It improves blood sugar control and reduces cardiovascular risks in diabetic patients. Weight loss is often a beneficial side effect, but using it solely for weight loss in non-diabetic patients is considered “off-label” .
• Wegovy (Semaglutide, higher doses): Approved specifically for chronic weight management in people with obesity or those who are overweight with a related condition (like high blood pressure or sleep apnea). It uses higher maintenance doses to maximize the weight-loss effect .

💡 The Bottom Line

Doctors explain these medications don’t change what you can eat, but they fundamentally change how much you want to eat by targeting the biological drivers of hunger and fullness . They are most effective when paired with a reduced-calorie diet and increased physical activity, as the medication makes it easier to adhere to those lifestyle changes